BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2376 related articles for article (PubMed ID: 8104570)

  • 1. Effects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852.
    von Stamm U; Bröcker EB; von Depka Prondzinski M; Ruiter DJ; Rümke P; Broding C; Carrel S; Lejeune FJ
    Melanoma Res; 1993 Jun; 3(3):173-80. PubMed ID: 8104570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
    Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
    Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic dynamics of tumor progression in human malignant melanoma.
    Bröcker EB; Suter L; Brüggen J; Ruiter DJ; Macher E; Sorg C
    Int J Cancer; 1985 Jul; 36(1):29-35. PubMed ID: 3860479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
    Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
    Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells.
    Giacomini P; Aguzzi A; Pestka S; Fisher PB; Ferrone S
    J Immunol; 1984 Sep; 133(3):1649-55. PubMed ID: 6747299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
    van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
    J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic phenotype of pigment cell lesions: a study of melanoma, its precursor lesions and heterogeneity in metastatic melanoma.
    Ernstoff MS; Duray P; Stenn K; Kirkwood JM
    J Invest Dermatol; 1985 May; 84(5):430-2. PubMed ID: 3889169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10.
    Maio M; Gulwani B; Tombesi S; Ferrone S
    Cancer Immunol Immunother; 1989; 30(1):34-42. PubMed ID: 2513111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
    Maio M; Gulwani B; Morgano A; Ferrone S
    Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic profiles of individual-matched pairs of primary and melanoma metastases.
    Meije CB; Swart GW; Lepoole C; Das PK; Van den Oord JJ
    Hum Pathol; 2009 Oct; 40(10):1399-407. PubMed ID: 19386352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
    Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
    J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.
    Vacca A; Frassanito A; Rimoldi D; Dammacco F; Carrel S
    Anticancer Res; 1992; 12(1):1-9. PubMed ID: 1348919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes.
    Holzmann B; Bröcker EB; Lehmann JM; Ruiter DJ; Sorg C; Riethmüller G; Johnson JP
    Int J Cancer; 1987 Apr; 39(4):466-71. PubMed ID: 3104215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690.
    Kirkwood JM; Richards T; Zarour HM; Sosman J; Ernstoff M; Whiteside TL; Ibrahim J; Blum R; Wieand S; Mascari R
    Cancer; 2002 Sep; 95(5):1101-12. PubMed ID: 12209697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice.
    Van Muijen GN; Cornelissen LM; Jansen CF; Figdor CG; Johnson JP; Bröcker EB; Ruiter DJ
    Clin Exp Metastasis; 1991; 9(3):259-72. PubMed ID: 2060184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
    Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U
    Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma.
    Natali P; Bigotti A; Cavaliere R; Liao SK; Taniguchi M; Matsui M; Ferrone S
    Cancer Res; 1985 Jun; 45(6):2883-9. PubMed ID: 3157450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 119.